Posvar EL - Search Results

1

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

Radulovic LL, Cilla DD, Posvar EL, Sedman AJ, Whitfield LR. Radulovic LL, et al. Among authors: posvar el. J Clin Pharmacol. 1995 Oct;35(10):990-4. doi: 10.1002/j.1552-4604.1995.tb04015.x. J Clin Pharmacol. 1995. PMID: 8568017 Clinical Trial.

2

New drugs: first time in man.

Posvar EL, Sedman AJ. Posvar EL, et al. J Clin Pharmacol. 1989 Nov;29(11):961-6. doi: 10.1002/j.1552-4604.1989.tb03262.x. J Clin Pharmacol. 1989. PMID: 2600192 No abstract available.

3

The temporal effect of food on tacrine bioavailability.

Welty DF, Siedlik PH, Posvar EL, Selen A, Sedman AJ. Welty DF, et al. Among authors: posvar el. J Clin Pharmacol. 1994 Oct;34(10):985-8. doi: 10.1002/j.1552-4604.1994.tb01970.x. J Clin Pharmacol. 1994. PMID: 7836549 Clinical Trial.

4

Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects.

Posvar EL, Radulovic LL, Cilla DD Jr, Whitfield LR, Sedman AJ. Posvar EL, et al. J Clin Pharmacol. 1996 Aug;36(8):728-31. doi: 10.1002/j.1552-4604.1996.tb04242.x. J Clin Pharmacol. 1996. PMID: 8877677 Clinical Trial.

5

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.

Cilla DD Jr, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL. Cilla DD Jr, et al. Among authors: posvar el. Clin Pharmacol Ther. 1996 Dec;60(6):687-95. doi: 10.1016/S0009-9236(96)90218-0. Clin Pharmacol Ther. 1996. PMID: 8988072 Clinical Trial.

6

Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.

Sedman AJ, Posvar E. Sedman AJ, et al. Angiology. 1989 Apr;40(4 Pt 2):360-9. doi: 10.1177/000331978904000405. Angiology. 1989. PMID: 2539762 Clinical Trial.

7

Theophylline dosage adjustment during enoxacin coadministration.

Koup JR, Toothaker RD, Posvar E, Sedman AJ, Colburn WA. Koup JR, et al. Antimicrob Agents Chemother. 1990 May;34(5):803-7. doi: 10.1128/AAC.34.5.803. Antimicrob Agents Chemother. 1990. PMID: 2360819 Free PMC article.

8

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN. Randinitis EJ, et al. Among authors: posvar el. J Clin Pharmacol. 2003 Mar;43(3):277-83. doi: 10.1177/0091270003251119. J Clin Pharmacol. 2003. PMID: 12638396 Clinical Trial.

9

Clinical pharmacokinetics of pregabalin in healthy volunteers.

Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, Randinitis EJ, Corrigan BW, Haig GM, Boyd RA, Wesche DL. Bockbrader HN, et al. Among authors: posvar el. J Clin Pharmacol. 2010 Aug;50(8):941-50. doi: 10.1177/0091270009352087. Epub 2010 Feb 10. J Clin Pharmacol. 2010. PMID: 20147618 Clinical Trial.

10

Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.

Blum RA, Olson SC, Kohli RK, Horvath AM, Sedman AJ, Posvar EL. Blum RA, et al. Among authors: posvar el. J Clin Pharmacol. 1990 Oct;30(10):938-42. doi: 10.1002/j.1552-4604.1990.tb03574.x. J Clin Pharmacol. 1990. PMID: 2229454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters